Page last updated: 2024-08-26

sarsasapogenin and Autosomal Dominant Juvenile Parkinson Disease

sarsasapogenin has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brotchie, JM; Callizot, N; Dixon, K; Howson, PA; Johnston, TH; Orsi, A; Rees, DD; Visanji, NP	1

Other Studies

1 other study(ies) available for sarsasapogenin and Autosomal Dominant Juvenile Parkinson Disease

Article	Year
PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:7 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Disease Models, Animal; Glial Cell Line-Derived Neurotrophic Factor; Male; Mesencephalon; Mice; Nerve Growth Factors; Neurons; Neurotoxins; Parkinsonian Disorders; Rats; Spirostans; Tyrosine 3-Monooxygenase	2008

Article

Year

PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:7

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Disease Models, Animal; Glial Cell Line-Derived Neurotrophic Factor; Male; Mesencephalon; Mice; Nerve Growth Factors; Neurons; Neurotoxins; Parkinsonian Disorders; Rats; Spirostans; Tyrosine 3-Monooxygenase

2008